4D Molecular Therapeutics, Inc 10-K for FY2022
4D Molecular Therapeutics, Inc. (FDMT)
10-K
2023-03-15
For: 2022-12-31
View Original
Added on
April 08, 2026
About this 10-K
4D Molecular Therapeutics, Inc filed this 10-K on March 15, 2023, covering the fiscal year ended December 31, 2022 (FY2022).
Headline figures
Fiscal year ended December 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $3.13M
- down 82.7% from $18.04M a year earlier
- Net loss
- $107.49M
- compared with a net loss of $71.32M a year earlier
- Diluted EPS
- -$3.32
- compared with -$2.57 a year earlier